Antiretroviral Therapy, Highly Active
Biological Markers
Drug Administration Schedule
Female
Fibrin Fibrinogen Degradation Products
HIV Infections
HIV Integrase Inhibitors
HIV Long Terminal Repeat
HIV-1
Humans
Male
Middle Aged
Pyrrolidinones
Treatment Outcome
Virus Replication
